ID
12429
Description
Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®; ODM derived from: https://clinicaltrials.gov/show/NCT02124785
Link
https://clinicaltrials.gov/show/NCT02124785
Keywords
Versions (2)
- 11/17/15 11/17/15 -
- 11/17/15 11/17/15 - Julian Varghese
Uploaded on
November 17, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatitis A NCT02124785
Eligibility Hepatitis A NCT02124785
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
History of hepatitis
Data type
boolean
Alias
- UMLS CUI [1]
- C1997459
Description
Hepatitis A Vaccines
Data type
boolean
Alias
- UMLS CUI [1]
- C0170300
Description
Immunosuppressive or immunodeficient condition
Data type
boolean
Alias
- UMLS CUI [1]
- C0021079
- UMLS CUI [2]
- C0021051
Description
Hepatitis A immunoglobulin
Data type
boolean
Alias
- UMLS CUI [1]
- C3652495
Description
Administration of immunosuppressants
Data type
boolean
Alias
- UMLS CUI [1]
- C0021081
- UMLS CUI [2]
- C0279021
Description
Administration of long-acting immune-modifying drugs (e.g. infliximab)
Data type
boolean
Alias
- UMLS CUI [1]
- C1134703
Description
Study Subject Participation Status
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Hepatitis A NCT02124785
- StudyEvent: Eligibility
C0021051 (UMLS CUI [2])
C0279021 (UMLS CUI [2])